AON
54
2
NOC
43
11
XYL
49
4
MAT
46
12
A
43
2
PLD
56
8
ILMN
42
5
NWL
53
3
BMY
60
2
EMN
60
4
HSIC
56
5
GS
75
2
PSA
58
2
VMC
57
4
KEY
46
3
DE
63
3
INTC
33
-2
EBAY
47
4
STZ
54
-3
PFG
45
3
AON
54
2
NOC
43
11
XYL
49
4
MAT
46
12
A
43
2
PLD
56
8
ILMN
42
5
NWL
53
3
BMY
60
2
EMN
60
4
HSIC
56
5
GS
75
2
PSA
58
2
VMC
57
4
KEY
46
3
DE
63
3
INTC
33
-2
EBAY
47
4
STZ
54
-3
PFG
45
3
Financhill
Back

Protalix BioTherapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
79

PLX
Protalix BioTherapeutics

Last Price:
1.70
Seasonality Move:
86.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Protalix BioTherapeutics Price Quote

$1.70
+0.01 (+2.41%)
(Updated: November 23, 2024 at 5:49 AM ET)

Protalix BioTherapeutics Key Stats

Buy
79
Protalix BioTherapeutics (PLX) is a Buy
Day range:
$1.66 - $1.78
52-week range:
$0.82 - $1.90
Dividend yield:
0%
P/E ratio:
18.78
P/S ratio:
2.91
P/B ratio:
3.84%
Volume:
545.6K
Avg. volume:
367.2K
1-year change:
19.86%
Market cap:
$124.4M
Revenue:
$65.5M
EPS:
$-0.16

How Much Does Protalix BioTherapeutics Make?

Is Protalix BioTherapeutics Growing As A Company?

Protalix BioTherapeutics Stock Price Performance

What Is Protalix BioTherapeutics 52-Week High & Low?

Protalix BioTherapeutics Price To Free Cash Flow

Is It Risky To Buy Protalix BioTherapeutics?

Is Protalix BioTherapeutics Cash Flow Positive?

  • What Is PLX Cash Flow From Operations?
    Cash flow from operations (TTM) is $8.3M
  • What Is Protalix BioTherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$20.4M
  • What Is Protalix BioTherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $19.2M

Protalix BioTherapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PLX return on invested capital is -19.69%
  • What Is Protalix BioTherapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -11.58%
  • What Is PLX Return On Equity?
    ROE is a measure of profitability and is -29.54%

Protalix BioTherapeutics Earnings Date & Stock Price

Protalix BioTherapeutics Competitors

Protalix BioTherapeutics Dividend Yield

Protalix BioTherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 73.6% 9.72%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.00
Upside from Last Price: 728.4%

Major Shareholders

  • How many PLX shares are owned by institutional investors?
    6.5M PLX shares are owned by institutional investors
  • How many PLX shares are owned by insiders?
    4.7M PLX shares are owned by insiders